Episode 5: Importance of Scalable Cell Therapy Manufacturing Processes
Episode 5 of the 7 part, Translating Cell Therapy Research into Clinical Success: A Gibco CTS Mini-Documentary Series.
We asked four experts with backgrounds in stem cell therapy and immunotherapy research, cell therapy manufacturing, and clinical development to share their unique perspectives on the opportunities and challenges facing the cell therapy industry. In each of the 7 videos these leaders provide practical guidance and valuable insights on a range of topics critical to successfully translating cell therapy research into clinical and commercial applications.
Contributors:
Larry A. Couture, Ph.D - Vice President, Center for Applied Technology Development, City of Hope
Michael Scott, Ph.D. – Chief Development Officer and Vice President, Device Research and Development, Viacyte, Inc.
Kevin D’Amour, Ph.D. – Chief Scientific Officer, Vice President of Research, Viacyte, Inc.
Holly Young – Cell Manufacturing Manager, Viacyte, Inc.
Special thanks to Viacyte, Inc and City of Hope for their incredible contributions and for helping to lead the field of cell therapy research forward.
To watch the next video in this mini-series and to learn more about Gibco Cell Therapy Systems (CTS) solutions available from Thermo Fisher Scientific, please visit: https://www.thermofisher.com/celltherapy
Watch video Episode 5: Importance of Scalable Cell Therapy Manufacturing Processes online without registration, duration hours minute second in high quality. This video was added by user Thermo Fisher Scientific 13 October 2015, don't forget to share it with your friends and acquaintances, it has been viewed on our site 1,820 once and liked it 8 people.